Genomictree Inc. (228760) — Free Cash Flow Generation Index

Latest as of December 2022: 0.57x

Genomictree Inc. (228760) has a Free Cash Flow Generation Index of 0.57x as of December 2022. Free cash flow of ₩2.46 Billion represents 1% of operating cash flow (₩4.29 Billion). See Genomictree Inc. current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.57x

Free Cash Flow / Operating CF

Free Cash Flow

₩2.46 Billion

KRW

Operating Cash Flow

₩4.29 Billion

KRW

Capital Expenditures

₩1.82 Billion

KRW

Genomictree Inc. Free Cash Flow Generation Index (2022–2022)

Historical FCF Generation Index trend for Genomictree Inc. across 1 annual periods. Explore 228760 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Genomictree Inc. (2022–2022)

Year-by-year Free Cash Flow Generation Index for Genomictree Inc.. For the full company profile including market capitalisation, see 228760 stock market capitalisation.

Year	FCG Index	Free Cash Flow (KRW)	Operating CF	Capital Expenditures	YoY Change
2022	0.57x	₩2.46 Billion	₩4.29 Billion	₩1.82 Billion	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).